Asia Pacific to record fastest growth in plasma therapy market

Thanks to increasing investments in healthcare infrastructure.

The Asia Pacific region is projected to be the fastest-growing market for plasma therapy from 2024 to 2032, according to SNS Insider.

The region’s expansion is attributed to the rapid adoption of the treatment in countries like China, Japan, and India due to increasing investments in healthcare infrastructure and awareness about regenerative medicine.

“Large corporations like Regen Lab SA are experiencing more opportunities in this region owing to increased demand for aesthetic treatments and minimally invasive procedures,” the report said.

Moreover, ongoing healthcare system improvements, along with research and development initiatives, will further drive the region’s market.

Meanwhile, the global market is projected to reach $1.087b during the forecast period.

This reflects a compound annual growth rate of 11.25%, fuelled by rising demand for minimally invasive procedures and an ageing population.